covid
Buscar en
Revista Colombiana de Cardiología
Toda la web
Inicio Revista Colombiana de Cardiología Correlación entre la medición en consultorio y la monitorización ambulatoria ...
Journal Information
Vol. 20. Issue 4.
Pages 190-197 (July - August 2013)
Share
Share
Download PDF
More article options
Vol. 20. Issue 4.
Pages 190-197 (July - August 2013)
Open Access
Correlación entre la medición en consultorio y la monitorización ambulatoria de la presión arterial en pacientes hipertensos de Medellín, Colombia
Correlation between the blood pressure measurement in office and ambulatory monitoring in hypertensive patients in Medellín, Colombia
Visits
2088
Santiago Patiño1,
Corresponding author
drsapg@gmail.com

Correspondencia.
, Juan M. Toro2, Carlos Jaramillo2, Héctor García2, Mónica Giraldo2
1 Universidad de Antioquia, Medellín, Colombia
2 Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia
This item has received

Under a Creative Commons license
Article information
Introducción

investigaciones recientes refieren mayor correlación entre la monitorización ambulatoria de la presión arterial (MAPA) y el compromiso de órgano blanco. Este estudio busca establecer la correlación entre la medición de la presión arterial en consultorio y la MAPA en pacientes con diagnóstico reciente de hipertensión arterial.

Métodos

pacientes con diagnóstico reciente de hipertensión arterial sin otros factores de riesgo cardiovascular. Se realizó toma de presión arterial en consultorio y MAPA. Se evaluó correlación entre las mediciones de presión arterial en consultorio y variables de la MAPA. Se categorizó el control de la hipertensión arterial de acuerdo con las guías del Joint National Committee 7 y la American Heart Association.

Resultados

se hicieron 239 MAPA en 149 sujetos con una media (DE) de presión arterial sistólica y presión arterial diastólica clínica de 134,5 (13,8) mm Hg y 87,5 (9) mm Hg y en 24 horas de 129 (10,4) mm Hg y 80,1 (7,5) mm Hg, respectivamente, con una diferencia de -4,95mm Hg (IC95%: -2,7; -7,2) y -7,4mm Hg (IC95%: -5,9; -8,9) con respecto a la presión arterial clínica. Se encontró correlación entre la presión arterial clínica y las variables de MAPA (presión arterial sistólica r=0,4; p<0,01, presión arterial diastólica r=0,48; p < 0,01). Para el control de la presión arterial con la toma clínica se encontró 43,7% de sensibilidad y 72,4% de especificidad en comparación con el otro método.

Conclusión

existe correlación positiva entre la medición de la presión arterial clínica y por MAPA, pero la sensibilidad y especificidad de una sola medición en consultorio con respecto a la MAPA, la hace insuficiente para verificar el control de la presión arterial.

Palabras clave:
monitorización ambulatoria de presión arterial
hipertensiónpresión arterial
sensibilidad
especificidad
Introduction

Recent studies reported higher correlation between ambulatory blood pressure monitoring (ABPM) and end-organ damage. This study aims to establish the correlation between office blood pressure measurement (OBPM) and ABPM in patients with newly diagnosed hypertension.

Methods

Patients newly diagnosed with hypertension without other cardiovascular risk factors. OBPM and ABPM were performed. We evaluated the correlation between OBPM and ABPM variables. Hypertensive control was categorized in accordance with the Joint National Committee 7 and American Heart Association guidelines.

Results

239 ABPM in 149 subjects with a mean (SD) office SBP and DBP 134.5 (13.8) mmHg and 87.5 (9) mmHg and 24-hours SBP of 129 (10.4) mmHg and 24-hours DBP 80.1 (7.5) mmHg, a difference of -4.95mmHg (95% CI: -2.7, -7.2) and -7.4mmHg (95% CI: -5.9, -8.9) with respect to office BP. Positive correlation was found between office BP and ABPM variables (SBP r=0.4, p <0.01, DBP r=0.48, p <0.01).Sensitivity and specificity of office BP versus AMPB for hypertensive control were 43.7% and 72.4% respectively.

Conclusion

There is positive correlation between OBPM and ABPM, but the sensitivity and specificity of a single measurement at office with regard to ABPM, makes it inadequate for evaluation of hypertensive control.

Key words:
blood pressure monitoring
ambulatory
hypertension
blood pressure
sensitivity
specificity
Full text is only aviable in PDF
Bibliografía
[1.]
Departamento Administrativo Nacional de Estadística. Principales causas de defunción año 2009 Colombia. [Sitio de Internet]; Disponible en: http://www.dane.gov.co/daneweb_V09/index.php?option=com_content&view=article&id=73&Itemid=119. Consultado: 04 de junio de 2011.
[2.]
European Society of Hypertension–European Society of, Cardiology, Guidelines Committee.
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.
J Hypertens, 21 (2003), pp. 1011-1053
[3.]
J.A. Staessen, E.T. O’Brien, L. Thijs, R. Fagard.
Modern approaches to blood pressure measurement.
Occup Environ Med, 57 (2000), pp. 510-520
[4.]
T.G. Pickering, N.H. Miller, G. Ogedegbe, L.R. Krakoff, N.T. Artinian, D. Goff.
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association American Society of Hypertension, and Preventive Cardiovascular Nurses Association.
[5.]
T. Ohkubo, M. Kikuya, H. Metoki, K. Asayama, T. Obara, J. Hashimoto, et al.
Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
J Am Coll Cardiol, 46 (2005), pp. 508-515
[6.]
M.G. Myers.
Current status of ambulatory blood pressure monitoring.
Can J Cardiol, 20 (2004), pp. 1424-1428
[7.]
B.J. Powers, M.K. Olsen, V.A. Smith, R.F. Woolson, H.B. Bosworth, E.Z. Oddone.
Measuring Blood Pressure for Decision Making and Quality Reporting: Where and How Many Measures?.
[8.]
J.R. Banegas, J. Segura, J. Sobrino, F. Rodriguez-Artalejo, A. de la Sierra, J.J. de la Cruz, et al.
Effectiveness of blood pressure control outside the medical setting.
[9.]
A. Jula, P. Puukka, H. Karanko.
Multiple clinic and home blood pressure measurements versus ambulatory blood pressure monitoring.
Hypertension, 34 (1999), pp. 261-266
[10.]
K.A. Pearce, G.W. Evans, J. Summerson, J.S. Rao.
Comparisons of ambulatory blood pressure monitoring and repeated office measurements in primary care.
J Fam Pract, 45 (1997), pp. 426-433
[11.]
P. Palatini, F. Dorigatti, A. Mugellini, V. Spagnuolo, N. Vari, R. Ferrara, et al.
Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Clin Ther, 26 (2004), pp. 1436-1445
[12.]
S. Ragot, N. Genes, L. Vaur, D. Herpin.
Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response.
Am J Hypertens, 13 (2000), pp. 632-639
[13.]
M.R. Hanninen, T.J. Niiranen, P.J. Puukka, A.M. Jula.
Comparison of home and ambulatory blood pressure measurement in the diagnosis of masked hypertension.
J Hypertens, 28 (2010), pp. 709-714
[14.]
K. Lovibond, S. Jowett, P. Barton, M. Caulfield, C. Heneghan, F.D.R. Hobbs, et al.
Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study.
Lancet, 378 (2011), pp. 1219-1230
[15.]
M.H. Prat, S.G. Valdés, A.Ó. Román, M.L.H. Zarate.
Actualización de las recomendaciones sobre el uso de la monitorización ambulatoria de presión arterial Documento de consenso de la Sociedad Chilena de Hipertensión.
Rev Med Chil, 137 (2009), pp. 1235-1247
[16.]
P. Delsart, P. Marboeuf, C. Delhaye, G. Lemesle, C. Mounier-Vehier.
Should we screen for masked hypertension in patient with vascular disease?.
Vasc Health Risk Manag, 6 (2010), pp. 333-338
[17.]
G. Parati, L.R. Krakoff, P. Verdecchia.
Methods of measurements: home and ambulatory blood pressure monitoring.
Blood Press Monit, 15 (2010), pp. 100-105
[18.]
E.M. Rosa, C.F. el Andari, M. Menegotto.
Relevant points for the evaluation of cardiovascular risk with the use of ABPM.
Arq Bras Cardiol, 95 (2010), pp. 764
[19.]
M.L. Burr, E. Dolan, E.W. O’Brien, E.T. O’Brien, P. McCormack.
The value of ambulatory blood pressure in older adults: the Dublin outcome study.
Age Ageing, 37 (2008), pp. 201-206
[20.]
K. Eguchi, T.G. Pickering, S. Hoshide, J. Ishikawa, S. Ishikawa, J.E. Schwartz, et al.
Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes.
Am J Hypertens, 21 (2008), pp. 443-450
[21.]
M. Gorostidi, J. Sobrino, J. Segura, C. Sierra, A. de la Sierra, R. Hernández del Rey, et al.
Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain.
J Hypertens, 25 (2007), pp. 977-984
[22.]
G. Mule, E. Nardi, G. Andronico, S. Cottone, F. Raspanti, G. Piazza, et al.
Relationships between 24 h blood pressure load and target organ damage in patients with mild-to-moderate essential hypertension.
Blood Press Monit, 6 (2001), pp. 115-123
[23.]
J.A. Staessen, L. Thijs, R. Fagard, E.T. O’Brien, D. Clement, P.W. de Leeuw, et al.
Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension Systolic Hypertension in Europe Trial Investigators.
JAMA, 282 (1999), pp. 539-546
[24.]
F.J. Félix-Redondo, D. Fernández-Berges, J. Espinosa-García, J. Pozuelos-Estrada, L.M. Molina-Martínez, J.F. Pérez-Castan, et al.
Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
Cardiol J, 16 (2009), pp. 57-67
[25.]
J. Hodgkinson, J. Mant, U. Martin, B. Guo, F.D.R. Hobbs, J.J. Deeks, et al.
Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review.
BMJ, 342 (2011), pp. d3621
[26.]
G.A. Head, A.S. Mihailidou, K.A. Duggan, L.J. Beilin, N. Berry, M.A. Brown, et al.
Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study.
BMJ, 340 (2010), pp. c1104
[27.]
R. McManus, U. Martin.
Differences in clinic and ambulatory measurements of blood pressure.
BMJ, 340 (2010), pp. c1782
[28.]
R.R. Quinn, B.R. Hemmelgarn, R.S. Padwal, M.G. Myers, L. Cloutier, P. Bolli, et al.
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I–blood pressure measurement, diagnosis and assessment of risk.
Can J Cardiol, 26 (2010), pp. 241-248
[29.]
R.E. Warren, T. Marshall, P.L. Padfield, S. Chrubasik.
Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements.
Br J Gen Pract, 60 (2010), pp. 675-680
[30.]
C.S. Rodrigues, K.V. Bloch, A. da Rocha Nogueira.
Office blood pressure and 24- hour ambulatory blood pressure measurements: high proportion of disagreement in resistant hypertension.
J Clin Epidemiol, 62 (2009), pp. 745-751
[31.]
R.S. Taylor, J. Stockman, D. Kernick, D. Reinhold, A.C. Shore, J.E. Tooke.
Ambulatory blood pressure monitoring for hypertension in general practice.
J R Soc Med, 91 (1998), pp. 301-304
[32.]
Pinilla-Roa A, Barrera-Perdomo MP, Agudelo-Uribe JF, Agudelo-Calderón C, Pardo R, Gaitán H, et al. Guía de atención de la hipertensión arterial. [Sitio en Internet]. Disponible en: http://www.nacer.udea.edu.co/pdf/libros/guiamps/guias13.pdf. Consultado: 06 de junio de 2011.
[33.]
G. Márquez, A. Muñoz, L. Otero, N. Roa, A.C. Palacio, P. Peña, et al.
Guías Colombianas para el diagnóstico y tratamiento de la hipertensión arterial.
Rev Col Cardiol, 13 (2007), pp. 187-317
[34.]
J. Goodwin, M. Bilous, S. Winship, P. Finn, S. Jones.
Validation of the Oscar 2 oscillometric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol.
Blood Press Monit, 12 (2007), pp. 113-117
[35.]
S. Jones, M. Bilous, S. Winship, P. Finn, J. Goodwin.
Validation of the OSCAR 2 oscillometric 24-hour ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices.
Blood Press Monit, 9 (2004), pp. 219-223
[36.]
T. Pickering, J. Hall, L. Appel, B. Falkner, J. Graves, M. Hill.
Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.
Circulation, 111 (2005), pp. 697-716
[37.]
G. Block, B. Sternfeld, C.H. Block, T.J. Block, J. Norris, D. Hopkins, et al.
Development of Alive (A Lifestyle Intervention Via Email), and its effect on health-related quality of life, presenteeism, and other behavioral outcomes: randomized controlled trial.
J Med Internet Res, 10 (2008), pp. e43
[38.]
K. Jamerson, M.A. Weber, G.L. Bakris, B. Dahlöf, B. Pitt, V. Shi, et al.
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
N Engl J Med, 359 (2008), pp. 2417-2428
[39.]
T. Mengden, B. Weisser, B. Vetter.
Ambulatory 24-h blood pressure versus selfmeasured blood pressure in pharmacologic trials.
J Cardiovasc Pharmacol, 24 (1994), pp. S5-S20
[40.]
J. Graves, B. Grossardt.
Discarding the first of three nurse-auscultatory or oscillometric blood pressure measurements does not improve the association of office blood pressure with ABPM.
Blood Press Monit, 15 (2010), pp. 146-151
[41.]
D. Aristizábal, S. Vélez, L. Báez, R. D‘Achiardi, E.M. Blanco de, F. Garrido.
Guías colombianas para el diagnóstico y tratamiento de la hipertensión arterial.
Rev Col Cardiol, 13 (2007), pp. 189-317
[42.]
National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 [sitio de Internet]. London: Royal College of Physicians (UK); 2011 Aug. (NICE Clinical Guidelines, No. 127.) Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK83274/. Consultado: 04 de junio de 2011.
[43.]
O. Friedman, A.G. Logan.
Can nocturnal hypertension predict cardiovascular risk?.
Integr Blood Press Control, 2 (2009), pp. 25-37
[44.]
O. Friedman, A.G. Logan.
Nocturnal blood pressure profiles among normotensive, controlled hypertensive and refractory hypertensive subjects.
Can J Cardiol, 25 (2009), pp. e312-e316
[45.]
M. Tanaka, S. Fukuda, K. Mizuno, H. Kuratsune, Y. Watanabe.
Stress and coping styles are associated with severe fatigue in medical students.
Behav Med, 35 (2009), pp. 87-92
[46.]
S. Yusuf, K.K. Teo, J. Pogue, L. Dyal, I. Copland, H. Schumacher, G. Dagenais, P. Sleight, C. Anderson.
ONTARGET Investigators: Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med, 358 (2008), pp. 1547-1550

Este artículo es resultado de la investigación “Ensayo clínico controlado del efecto del consumo de cacao en parámetros cardiovasculares de hombres con diagnóstico reciente de hipertensión arterial esencial inscritos en un programa de manejo no farmacológico en una EPS de Antioquia” y “Ensayo clínico controlado del efecto del consumo de cacao en la disminución de la presión arterial y en la modulación de la inflamación endotelial en pacientes hipertensos adscritos a una entidad promotora de salud de Antioquia” financiados por Colciencias, con el apoyo parcial de la Estrategia de Sostenibilidad 2011-2012 de la Universidad de Antioquia. Los autores.

Copyright © 2013. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular
Download PDF
Article options